Pantheon Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Pantheon Investment Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$421K	Buy	661 +28	+4%	+$17.2K	0.33%	63
2021 Q3	$379K	Sell	633 -213	-25%	-$132K	0.33%	68
2021 Q2	$473K	Buy	+846	New	+$429K	0.4%	61
2021 Q1	–	Sell	-1,169	Closed	-$565K	–	72
2020 Q4	$565K	Sell	1,169 -433	-27%	-$234K	0.62%	53
2020 Q3	$897K	Buy	+1,602	New	+$971K	1.07%	37

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Pantheon Investment Group's REGN Position: Q4 2021 in Review

Pantheon Investment Group increased its Regeneron Pharmaceuticals (REGN) stake by 4.4% in Q4 2021, buying an estimated $17.2K and bringing the position to 661 shares worth $421K. The position accounts for 0.33% of the portfolio, ranked #63.

Pantheon Investment Group first reported a position in REGN in Q3 2020 and has held it in 5 quarters since. The position peaked at $897K in Q3 2020. 1,079 funds tracked by Wall St. Rank hold REGN as of Q4 2021.

Pantheon Investment Group held 661 shares of Regeneron Pharmaceuticals worth $421K as of Q4 2021.
Pantheon Investment Group bought 28 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $17.2K.
Regeneron Pharmaceuticals made up 0.33% of Pantheon Investment Group's portfolio in Q4 2021, its #63 holding.
Pantheon Investment Group first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 5 quarters since.
Pantheon Investment Group's Regeneron Pharmaceuticals position peaked at $897K in Q3 2020.
1,079 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.

Based on Pantheon Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.